NJ drug firms will spend billions to expand in U.S. Here's why
The expansion announcements come at a time when President Donald Trump has threatened massive tariffs on pharmaceutical imports to the U.S. Others say it's not certain if these plans — by Bristol Myers Squibb, Johnson & Johnson, Merck, Novartis, …